What is special about Plasauto SIGMA?In paediatrics, special requirements are placed on continuous renal replacement therapy and therapeutic apheresis. Precise balancing systems and measuring techniques as well as highly accurate adjustable flow rates for blood, plasma and ultrafiltrate are necessary, especially for small children. This is exactly what Plasauto SIGMA does.
Plasauto SIGMA – even for your youngest patients
- special blood tubing systems for renal replacement therapy with a small filling volume
- exact balancing systems and measuring techniques for the youngest and smallest patients
- successful immunoadsorption in pregnant patients
- Lipidfiltration with Plasauto SIGMA - the standard for dyslipidemia in children and adolescents
When is Plasauto SIGMA used?
Blood flow and withdrawal rates can be set with high precision to 1 ml/min, filtrate and substitution rates to 10 ml/h. Special blood tubing systems with a reduced filling volume of just 47ml are available for small children for all renal replacement therapy procedures. As a result, Plasauto SIGMA is even used to treat babies.
In lipid apheresis, the therapy of children with an increase in LDL cholesterol caused by homozygous familial hypercholesterolemia is essential. A current publication documents the treatment of 24 children and adolescents in Germany with lipid filtration and the Plasauto SIGMA device technology over a longer period of therapy. This is the largest systematic analysis of the therapy of homozygous children in Germany (Taylan et al., 2020).
In addition, Plasauto SIGMA is used in autoimmune diseases to remove autoantibodies in children and pregnant women. Tryptophan mmunoadsorption was used successfully and clinically effectively in 24 pregnant patients with multiple sclerosis in an acute relapse. All children were healthy at birth. (Hoffmann et al., 2018).
All this makes Plasauto SIGMA the market leader for extracorporeal blood purification in paediatrics.
Would you like to learn more about our products and solutions?Contact us
Plasauto SIGMA device technology
Plasauto SIGMA - the market leader from Japan - for continuous renal replacement therapy and therapeutic apheresis. Suitable even for the youngest and smallest patients! Whether citrate or heparin, outpatient or inpatient - the choice is yours!
Therapy solutions for healthcare professionals
What in particular are you interested in? Please select.
The following information is intended for healthcare professionals only.
The information in the section ‚products & therapies‘ is intended to provide explanatory, scientific, and evidence-based answers to medical questions about therapeutic apheresis.
This information does not constitute medical advice. The responsibility for patient care rests with the healthcare professional based on their professional licensure, experience, and knowledge of the patient.